Acute Myeloid Leukaemia clinical trials

Explore recruiting acute myeloid leukaemia clinical trials.

Recruiting acute myeloid leukaemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Myeloid Leukaemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, phase 2 study, evaluating the efficacy of treatment with Gilteritinib in measurable residual disease eradication in patients with FLT3-ITD mutated acute myeloid leukemia

Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

MITHRIDATE: A phase III, randomised, open-label, Multicenter International Trial comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

HOVON 171 AML: A single arm phase II trial to assess cobicistat boosted venetoclax in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (AML) who are not considered candidates for intensive treatment regimens

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

VICTOR: Venetoclax or Intensive Chemotherapy for Treatment Of Favourable Risk Acute Myeloid Leukaemia: a molecularly guided phase 2 study

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Open Label Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in combination with Azacitidine after allogeneic Stem Cell Transplantation in Subjects with Acute Myeloid Leukemia (AML) (VIALE-T)

Czechia, Hungary, Spain, Italy, Germany, Greece +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

HEAT-AML (Hydroxyurea-Enhanced Ara-C Treatment of Adult Acute Myeloid Leukaemia): A phase I/II multi-centre study to assess the tolerability and efficacy of the addition of hydroxyurea to standard ara-C and daunorubicin-based therapy for adults (age ≥ 18 years of age) with newly diagnosed acute myeloid leukaemia (AML)

Sweden

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Acute Myeloid Leukaemia trials by city

Acute Myeloid Leukaemia in Toronto Acute Myeloid Leukaemia in Vancouver Acute Myeloid Leukaemia in Montreal Acute Myeloid Leukaemia in Calgary Acute Myeloid Leukaemia in Edmonton Acute Myeloid Leukaemia in Ottawa Acute Myeloid Leukaemia in Winnipeg Acute Myeloid Leukaemia in Quebec City Acute Myeloid Leukaemia in Hamilton Acute Myeloid Leukaemia in Kitchener Acute Myeloid Leukaemia in London Acute Myeloid Leukaemia in Halifax Acute Myeloid Leukaemia in New York Acute Myeloid Leukaemia in Los Angeles Acute Myeloid Leukaemia in Chicago Acute Myeloid Leukaemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease